Story perspectives

Lizzo Rejects Settlement, Dancers Cite Harassment Allegations

5/5/2026

Summary

Lizzo Rejects Settlement

Lizzo told Gayle King on May 4, 2026 she will not settle 2023 lawsuit.
Dancers Arianna Davis, Crystal Williams and Noelle Rodriguez sued Lizzo in 2023 alleging sexual harassment, fat-shaming and a hostile work environment.
A judge dismissed the fat-shaming claim in December 2023.
The case still alleges Lizzo pressured a dancer to touch a nude performer in Amsterdam’s Red Light District in February 2023, while she plans to release her fifth album Bitch on June 5, 2026.

Summary

Lizzo Rejects Medication

Lizzo said she lost weight by a calorie deficit, cardio and protein, not medication.
She said she briefly tried a GLP-1 drug but stopped because she fears needles and it didn’t work.
Lizzo said she released anxiety and depression and affirmed she is not a skinny person.
She hopes to resume touring soon, saying her music and heart are strong.
She wants to inspire others to pursue their own journeys.

History

Historical Context

In 2005 the FDA approved Amylin’s GLP-1 drug exenatide, marketed as Byetta, which had over 1 million U.S. prescriptions by 2019 and sparked debate over diabetes versus weight-loss use. The Byetta launch showed how new GLP-1 approvals can fuel media attention, a pattern echoed today by Lizzo’s 2023 GLP-1 trial and related lawsuit.

1 of 3

Lizzo Rejects Settlement

Lizzo told Gayle King on May 4, 2026 she will not settle 2023 lawsuit.
Dancers Arianna Davis, Crystal Williams and Noelle Rodriguez sued Lizzo in 2023 alleging sexual harassment, fat-shaming and a hostile work environment.
A judge dismissed the fat-shaming claim in December 2023.
The case still alleges Lizzo pressured a dancer to touch a nude performer in Amsterdam’s Red Light District in February 2023, while she plans to release her fifth album Bitch on June 5, 2026.

1 / 3